Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of human chorionic gonadotropin on infertility treatment
IRCT2017012932284N1Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Feb 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of human chorionic gonadotropin in infertility, sponsored by Babol University of Medical Sciences. Started Feb 2017; status: completed.
02
Drugs
human chorionic gonadotropin
03
Conditions
infertility
Beyond the preview
Go deeper on IRCT2017012932284N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017012932284N1.